News

stamcel- en gentherapie
Bridging the Gap: new PharmaNL project strengthens continuing education in stem cell and gene therapy
May 28, 2026

“The cell and gene therapy field is evolving so rapidly that it is almost impossible for professionals to always stay up to date,” says Niels Geijsen, Head of the Department of Anatomy and Embryology at the Leiden University Medical Center (LUMC). With the newly awarded project Bridging the Gap, one of six projects funded in […]

PharmaNL Community Event brings the Dutch pharmaceutical sector together in Utrecht
May 21, 2026

With more than 80 participants from across the Dutch pharmaceutical innovation ecosystem, the PharmaNL Community Event on Wednesday, 20 May focused on connection, knowledge sharing, and shared ambition. Held at the Jaarbeurs in Utrecht, the event brought together researchers, educational institutions, companies, startups, and policymakers to reflect on the first results of PharmaNL and to […]

fermentation and bioprocessing
New education programmes in fermentation and bioprocessing strengthen the Dutch pharma ecosystem
May 7, 2026

“Those who don’t understand the latest technologies risk losing the competitive position of the Dutch pharmaceutical value chain,” warns Sven Stielstra, manager LIFE Capital at the LIFE Cooperative and project lead of the new PharmaNL initiative Fermentation and Bioprocessing for Smart and Sustainable Pharma. This project, launched at the beginning of 2026 within PharmaNL’s Human […]

IMED
IMED: filling the gap in molecular imaging education
April 23, 2026

“There is simply no structured education in molecular imaging to support drug development,” says internist-oncologist Derk Jan de Groot of the UMCG. With the new IMED (IMaging EDucation) project, UMCG, together with project partners Hanze and the LIFE Cooperative, aims to change that. The project, recently awarded within PharmaNL’s Human Capital Growth programme and made […]

Miranda van Eck
“Collaboration is key.” New board member Miranda van Eck on knowledge sharing and innovation in the pharmaceutical sector
April 20, 2026

At the beginning of this year, Miranda van Eck joined the board of PharmaNL as a new board member. Van Eck is Professor of Cardiovascular and Metabolic Therapies at Leiden University. Since September 2024, she has also been Scientific Director of the Leiden Academic Center for Drug Research, where she leads one of the eight […]

Yorick Peterse
Meet PharmaNL: Yorick Peterse (Ministry of Health, Welfare and Sport). “PharmaNL brings together patient care and economic growth”
March 31, 2026

In the Meet PharmaNL series, we introduce the board, partners such as ZonMw, and policymakers who contribute to PharmaNL’s ambitions. The Dutch Ministry of Health, Welfare and Sport (VWS) plays a key role in this effort. With expertise in pharmaceutical policy, innovation, and the coordination of funding, VWS contributes to a strong and future-proof pharmaceutical […]

QPharmNL team
Modeling for Better Medicines: QPharmNL Project Launches
March 23, 2026

The recently awarded QPharmNL project, part of the PharmaNL Human Capital Growth (HCG) program, will launch in April 2026 with an innovative training program focused on computational pharmacological techniques in drug development. These techniques use mathematical models to map the relationship between dose, exposure, effects, and side effects of new medicines, enabling better translation of […]

ATMP projct kick off
From Lab to Practice: New Post-Bachelor ATMP Courses
March 3, 2026

Training professionals for Advanced Therapeutic Medicinal Products (ATMPs) is at the heart of one of the newest PharmaNL projects. In the recent October 2025 funding round, ZonMw awarded six projects within the Human Capital Growth program line of PharmaNL, aimed at strengthening the knowledge and skills of professionals in the pharmaceutical sector. One of these […]

vier nieuwe projecten
Four New Projects Launch under Shared Development Infrastructure
February 26, 2026

In the coming months, four new projects will get underway as part of the PharmaNL Shared Development Infrastructure (SDI) Call 2025, the second funding round within the PharmaNL SDI program line. The selected projects focus on building and/or upgrading infrastructure for the development, scale-up, and production of innovative medicines in the Netherlands. A total of […]

Call for Companies: Pilot Participation in Gentech and Bioanalysis Modules
February 19, 2026

Would your organisation like to train employees and introduce them to the latest developments in Gentech and Bioanalysis? The PharmaNL project Groningen Human Capital for Life Sciences invites companies to participate in the pilot phase of newly developed training modules. This project, part of PharmaNL’s Human Capital Growth programme line, focuses on developing innovative training […]